Tao Y - Search Results

1

The Role of MicroRNAs in Hepatocellular Carcinoma.

Xu X, Tao Y, Shan L, Chen R, Jiang H, Qian Z, Cai F, Ma L, Yu Y. Xu X, et al. Among authors: tao y. J Cancer. 2018 Sep 8;9(19):3557-3569. doi: 10.7150/jca.26350. eCollection 2018. J Cancer. 2018. PMID: 30310513 Free PMC article. Review.

2

Prognostic and clinicopathologic significance of SIRT1 expression in hepatocellular carcinoma.

Jiang H, Zhang X, Tao Y, Shan L, Jiang Q, Yu Y, Cai F, Ma L. Jiang H, et al. Among authors: tao y. Oncotarget. 2016 Dec 22;8(32):52357-52365. doi: 10.18632/oncotarget.14096. eCollection 2017 Aug 8. Oncotarget. 2016. PMID: 28881735 Free PMC article.

3

The Hippo signaling pathway: an emerging anti-cancer drug target.

Tao Y, Cai F, Shan L, Jiang H, Ma L, Yu Y. Tao Y, et al. Discov Med. 2017 Aug;24(130):7-18. Discov Med. 2017. PMID: 28950071 Free article. Review.

4

Huaier Restrains Proliferative and Migratory Potential of Hepatocellular Carcinoma Cells Partially Through Decreased Yes-Associated Protein 1.

Shan L, Li Y, Jiang H, Tao Y, Qian Z, Li L, Cai F, Ma L, Yu Y. Shan L, et al. Among authors: tao y. J Cancer. 2017 Nov 6;8(19):4087-4097. doi: 10.7150/jca.21018. eCollection 2017. J Cancer. 2017. PMID: 29187885 Free PMC article.

5

Bufalin inhibits cell proliferation and migration of hepatocellular carcinoma cells via APOBEC3F induced intestinal immune network for IgA production signaling pathway.

Yang Z, Tao Y, Xu X, Cai F, Yu Y, Ma L. Yang Z, et al. Among authors: tao y. Biochem Biophys Res Commun. 2018 Sep 10;503(3):2124-2131. doi: 10.1016/j.bbrc.2018.07.169. Epub 2018 Aug 6. Biochem Biophys Res Commun. 2018. PMID: 30100060

6

Nonsteroidal anti-inflammatory drugs, especially aspirin, are linked to lower risk and better survival of hepatocellular carcinoma: a meta-analysis.

Tao Y, Li Y, Liu X, Deng Q, Yu Y, Yang Z. Tao Y, et al. Cancer Manag Res. 2018 Aug 15;10:2695-2709. doi: 10.2147/CMAR.S167560. eCollection 2018. Cancer Manag Res. 2018. PMID: 30147368 Free PMC article.

7

Huaier Augmented the Chemotherapeutic Sensitivity of Oxaliplatin via Downregulation of YAP in Hepatocellular Carcinoma.

Tao Y, Shan L, Xu X, Jiang H, Chen R, Qian Z, Yang Z, Liang B, Zheng H, Cai F, Yu Y, Ma L. Tao Y, et al. J Cancer. 2018 Oct 10;9(21):3962-3970. doi: 10.7150/jca.25909. eCollection 2018. J Cancer. 2018. PMID: 30410600 Free PMC article.

8

The efficacy and safety of nivolumab, pembrolizumab, and atezolizumab in treatment of advanced non-small cell lung cancer.

Chen R, Tao Y, Xu X, Shan L, Jiang H, Yin Q, Pei L, Cai F, Ma L, Yu Y. Chen R, et al. Among authors: tao y. Discov Med. 2018 Oct;26(143):155-166. Discov Med. 2018. PMID: 30586539 Free article. Review.

9

Exosomes in hepatocellular carcinoma: a new horizon.

Chen R, Xu X, Tao Y, Qian Z, Yu Y. Chen R, et al. Among authors: tao y. Cell Commun Signal. 2019 Jan 7;17(1):1. doi: 10.1186/s12964-018-0315-1. Cell Commun Signal. 2019. PMID: 30616541 Free PMC article. Review.

10

miR-125a-5p inhibits tumorigenesis in hepatocellular carcinoma.

Xu X, Tao Y, Niu Y, Wang Z, Zhang C, Yu Y, Ma L. Xu X, et al. Among authors: tao y. Aging (Albany NY). 2019 Sep 17;11(18):7639-7662. doi: 10.18632/aging.102276. Epub 2019 Sep 17. Aging (Albany NY). 2019. PMID: 31527306 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

8,435 results

Search Page